Management of Biofilm with Breast Implant Surgery | Journal CME Article-Journal CME Article: Management of Biofilm with Breast Implant Surgery Video 3 of 7

Journal CME Article: Management of Biofilm with Breast Implant Surgery Video 3 of 7

Video Transcription

Video Summary

Evaluating the impact of bacterial biofilms in clinical studies faces challenges such as controlling variables like implant type, insertion plane, and infection risks. Management strategies vary, including the use of insertion funnels and antibiotics. Follow-up duration is crucial since implant infections often occur beyond 30 days post-surgery and capsular contracture rates can increase for over a decade. Most studies, however, have shorter follow-up times. There's a shortage of randomized control studies focusing on breast implants and antibiotics, with existing studies often outdated or not implant-specific. Precision medicine is needed to tailor antimicrobial approaches for individual patients.

Keywords

bacterial biofilms

implant infections

capsular contracture

precision medicine

randomized control studies